Alchemist Ltd.
Snapshot View

3.85 ▼0%

26 July 2021, 04:00:00 P.M.

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alchemist.com/www.alchemist.co.in
Financial Indicators
Market Cap 4.79 Cr.
Earnings per share (EPS) -168.44 Trailing Twelve Months Ending 2020-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2020-09
Industry PE 34.39 Trailing Twelve Months Ending 2020-09
Book Value / Share -282.72 Trailing Twelve Months Ending 2020-09
Price to Book Value -0.01 Calculated using Price: 3.53
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.36 Cr. 13,559,800 Shares
FaceValue 10
Company Profile

Alchemist incorporated in 1988 as Toubro Industries is engaged in the business of steel, floriculture, pharma, information technology, food processing and international business. The company is part of Rs.2000 crore Alchemist group. The company was promoted by Shri Kanwar Deep Singh.

Business Areas

Steel- Alchemist manufactures welded wire mesh in more than 100 grades. The company is amongst the largest manufacturers of welded wire mesh in India. The company exports its products to US and Middle East countries. Company manufacturing unit is located Kurali, Punjab with a manufacturing capacity of 4,000 mt. per annum of welded wire mesh and chain link. The  raw materials are sourced from companies like Rashtriya Ispat Nigam, Steel Authority of India, Tata Steel Limited and Usha Martins.

Healthcare- Company operates Alchemist Multi-Specialty Hospital that has capacity of 150-beds managed by panel of health experts. The hostipal is well equipped with latest technologies and facilities like 75 monitored beds, digital cardiac cath lab major operation theatres equipped with HEPA filters and MAC laminar vents.

Floriculture- Company’s Dappar unit is used for growing roses of Dutch and French varieties. Company has created a green house capacity of 45,000 sq. meters. It also conducts post harvest technology such as grading, packaging and storing.

Food Processing- Company operates an integrated poultry unit that comprises of hatchery, environmentally controlled growing farms and poultry processing plant with equipments for manufacturing ready eat food.  This facility is located in Punjab.

IT-Company comprises of designing e-businesses solutions, building B2B and B2C models, web hosting, inventory management solutions, application outsourcing solutions and payroll management solutions.

Awards and recognition

Company has received Rashtriya Ratan award given by Integration and Economic Council of India.

Company bagged Udyog Ratan Award by Institute of Economic Study, New Delhi

Future Plans

Alchemist is engaged in developing new products and services to strengthen its presence. The company also plans to explore untapped markets.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
+4.34%
1 Month
+0.52%
3 Month
+7.54%
6 Month
-7.45%
1 Year
-15.57%
2 Year
+234.78%
5 Year
-84.69%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 27.71 22.74 8.32 -34.63 -88.04
Return on Capital Employed (%) 9.57 9.74 4.54 -3.97 -5.89 -14.86 -2.26 -9.36 -9.70
Return on Assets (%) 5.27 5.21 1.44 -3.52 -5.25 -11.70 -2.04 -6.23 -6.28

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 105 178 136 87 35 -83 -100 -150 -196
Non Curr. Liab. 326 325 812 737 758 747 756 755 752
Curr. Liab. 81 44 193 192 197 172 166 164 161
Minority Int. 19 17 15 10 0 0 0 0
Equity & Liab. 512 566 1,159 1,030 999 835 822 770 717
Non Curr. Assets 359 460 500 481 445 346 336 332 326
Curr. Assets 150 104 658 548 554 489 486 438 391
Misc. Exp. not W/O 3 2
Total Assets 512 566 1,159 1,030 999 835 822 770 717

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 886 1,457 1,508 350 105 24 27 27 14
Other Income 12 16 22 22 22 3 2 1 0
Total Income 898 1,474 1,530 372 127 27 28 28 15
Total Expenditure -852 -1,417 -1,476 -375 -138 -53 -36 -80 -65
PBIDT 46 57 54 -3 -11 -26 -8 -52 -51
Interest -4 -7 -4 -5 -5 -2 -2 -1 -1
Depreciation -11 -12 -15 -23 -26 -8 -8 -7 -7
Taxation -7 -9 -15 1 -2 1 0 11 11
Exceptional Items -8 -8 -9 -72 1
PAT 24 28 12 -38 -53 -107 -17 -50 -47

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 15 4 -232 -98 -25 -14 -14 -7 -4
Cash Fr. Inv. -50 -98 -45 -9 -2 5 4 -3 0
Cash Fr. Finan. 92 53 427 -69 19 11 10 9 5
Net Change 57 -40 150 -175 -8 1 0 -1 0
Cash & Cash Eqvt 79 39 189 13 5 -1 -1 -2 -2

Shareholding Pattern View Details

9 Qtrs 2018-09 (%) 2018-12 (%) 2019-03 (%) 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%)
Promoter 34.94 34.94 34.94 34.94 34.94 34.94 34.94 34.94 34.94
Public 65.06 65.06 65.06 65.06 65.06 65.06 65.06 65.06 65.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Sat, 06 Feb 2021
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Ms. Divya Bajaj has resigned from the post of Company Secretary and compliance officer
Wed, 06 Jan 2021
Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0101
Name of the Signatory :- CHARANDEEP SINGH JOLLY
Designation :- Any Other
Mon, 04 Jan 2021
Closure of Trading Window
This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 as amended read with NSE Circular No. NSE/CML/2019/11 and BSE Circular No. LIST/COMP/01/2019-20 dated 2nd April 2019; the Trading Window for dealing in the securities of the Company shall remain closed for all Designated/Connected Persons with effect from Friday January 01 2021 till the end of 48 hours after declaration of Unaudited Financial Results for the Quarter ended on December 31 2020. All the Directors KMPs Designated Employees connected persons and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during the aforesaid period.
The date of Board Meeting for consideration and declaration of the Unaudited Financial Results for the Quarter ended on December 31 2020 shall be intimated to you separately

Technical Scans View Details

Mon, 26 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Strongly Underperforming Benchmark index Strongly Underperforming Benchmark index
Strongly Underperforming Sectoral index Strongly Underperforming Sectoral index
Both SRS And ARS Below Zero Both SRS And ARS Below Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,733.23 710.10 +1.0%
Divi's Laboratories Ltd. 128,656.69 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. 77,707.65 4,738.60 +1.4%
Cipla Ltd. 71,170.06 884.30 +0.2%
Cadila Healthcare Ltd. 58,547.84 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. 58,067.43 4,047.00 +0.2%
Aurobindo Pharma Ltd. 53,214.94 912.30 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.11 710.10 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 64.84 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 44.73 4,738.60 +1.4%
Cipla Ltd. Consolidated 2021-03 29.59 884.30 +0.2%
Cadila Healthcare Ltd. Consolidated 2021-03 27.44 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 386.19 4,047.00 +0.2%
Aurobindo Pharma Ltd. Consolidated 2021-03 9.98 912.30 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 710.10 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 13.84 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.35 4,738.60 +1.4%
Cipla Ltd. Consolidated 2021-03 3.88 884.30 +0.2%
Cadila Healthcare Ltd. Consolidated 2021-03 4.51 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.64 4,047.00 +0.2%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.43 912.30 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 710.10 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,738.60 +1.4%
Cipla Ltd. Consolidated 2020-03 0.18 884.30 +0.2%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,047.00 +0.2%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 912.30 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 710.10 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,738.60 +1.4%
Cipla Ltd. Consolidated 2020-03 10.09 884.30 +0.2%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,047.00 +0.2%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 912.30 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 710.10 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,738.60 +1.4%
Cipla Ltd. Consolidated 2020-03 12.53 884.30 +0.2%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,047.00 +0.2%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 912.30 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 710.10 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,738.60 +1.4%
Cipla Ltd. Consolidated 2020-03 17,131.99 884.30 +0.2%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,047.00 +0.2%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 912.30 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 710.10 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,877.70 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,738.60 +1.4%
Cipla Ltd. Consolidated 2020-03 1,546.98 884.30 +0.2%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 583.00 +1.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,047.00 +0.2%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 912.30 +0.4%